BAJAJ BROKING

Notification
No new Notification messages
Vishal Mega Mart IPO is Open!
Apply for the Vishal Mega Mart IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
medico remedies limited stock

MEDICO REMEDIES LIMITED Share Price

48.94 -0.84 (-1.68%)
Dec 12 2024 03:30 PM Pharmaceuticals NSE: MEDICO

MEDICO REMEDIES LIMITED Share Price Update

As of the latest trading session, MEDICO REMEDIES LIMITED share price is currently at 48.94, which is down by -0.84 from its previous closing. Today, the stock has fluctuated between 48.20 and 50.20. Over the past year, MEDICO REMEDIES LIMITED has achieved a return of -41.67 %. In the last month alone, the return has been -18.29 %. Read More...

MEDICO REMEDIES LIMITED Performance

Day Range

Low48.20 High50.20
48.94

52 Week Range

Low 34.80 High 92.95
48.94

MEDICO REMEDIES LIMITED Share Price

9667

540937

MEDICO

img img img img
No Data Available

Open Price

50.20

Prev. Close

49.78

Volume (Shares)

122224.00

Total traded value

59.81

Upper Circuit

54.75

Lower Circuit

44.80

Note: The current prices & values are delayed, Login to your account for live updates.

MEDICO REMEDIES LIMITED Fundamentals


(Standalone)

Market Cap (Cr) 406.10
PE Ratio (TTM) 53.44
Book Value / Share 6.68
Beta 0.47
ROE 17.23%
EPS (TTM) 0.93
Dividend Yield 0.00%
Net Profit Qtr (Cr) 1.55

MEDICO REMEDIES LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 39.35
Operating Expense 37.89
Net Profit 1.55
Net Profit Margin (%) 3.93
Earnings Per Share (EPS) 0.19
EBITDA 3.09
Effective Tax Rate (%) 27.23
Particulars JUN 2024 (Values in Cr)
Revenue 30.80
Operating Expense 28.91
Net Profit 1.58
Net Profit Margin (%) 5.12
Earnings Per Share (EPS) 0.19
EBITDA 3.11
Effective Tax Rate (%) 27.52
Particulars MAR 2024 (Values in Cr)
Revenue 41.32
Operating Expense 37.67
Net Profit 3.10
Net Profit Margin (%) 7.50
Earnings Per Share (EPS) 0.37
EBITDA 5.24
Effective Tax Rate (%) 27.05
Particulars DEC 2023 (Values in Cr)
Revenue 29.77
Operating Expense 27.98
Net Profit 1.45
Net Profit Margin (%) 4.87
Earnings Per Share (EPS) 0.17
EBITDA 3.00
Effective Tax Rate (%) 30.09
Particulars SEP 2023 (Values in Cr)
Revenue 42.36
Operating Expense 40.17
Net Profit 2.43
Net Profit Margin (%) 5.73
Earnings Per Share (EPS) 0.29
EBITDA 4.03
Effective Tax Rate (%) 22.92
Particulars MAR 2024 (Values in Cr)
Revenue 144.92
Operating Expense 135.70
Net Profit 8.29
Net Profit Margin (%) 5.72
Earnings Per Share (EPS) 1.00
EBITDA 15.03
Effective Tax Rate (%) 26.83
Particulars MAR 2023 (Values in Cr)
Revenue 140.44
Operating Expense 134.29
Net Profit 7.24
Net Profit Margin (%) 5.15
Earnings Per Share (EPS) 0.87
EBITDA 13.57
Effective Tax Rate (%) 28.31
Particulars MAR 2022 (Values in Cr)
Revenue 121.02
Operating Expense 116.56
Net Profit 4.81
Net Profit Margin (%) 3.97
Earnings Per Share (EPS) 2.90
EBITDA 9.36
Effective Tax Rate (%) 25.77
Particulars MAR 2021 (Values in Cr)
Revenue 122.39
Operating Expense 119.73
Net Profit 2.59
Net Profit Margin (%) 2.11
Earnings Per Share (EPS) 6.25
EBITDA 6.26
Effective Tax Rate (%) 29.53
Particulars MAR 2020 (Values in Cr)
Revenue 88.64
Operating Expense 88.52
Net Profit 1.63
Net Profit Margin (%) 1.83
Earnings Per Share (EPS) 3.93
EBITDA 4.94
Effective Tax Rate (%) 26.12
Particulars MAR 2024 (Values in Cr)
Book Value / Share 6.31
ROE % 17.23
ROCE % 21.24
Total Debt to Total Equity 0.19
EBITDA Margin 10.37
Particulars MAR 2023 (Values in Cr)
Book Value / Share 5.28
ROE % 18.00
ROCE % 21.01
Total Debt to Total Equity 0.28
EBITDA Margin 9.66
Particulars MAR 2022 (Values in Cr)
Book Value / Share 22.04
ROE % 13.93
ROCE % 14.74
Total Debt to Total Equity 0.40
EBITDA Margin 7.73
Particulars MAR 2021 (Values in Cr)
Book Value / Share 78.22
ROE % 8.31
ROCE % 10.11
Total Debt to Total Equity 0.46
EBITDA Margin 5.12
Particulars MAR 2020 (Values in Cr)
Book Value / Share 71.98
ROE % 5.61
ROCE % 7.64
Total Debt to Total Equity 0.47
EBITDA Margin 5.57
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.18
Total Assets 96.19
Total Liabilities 96.19
Total Equity 52.37
Share Outstanding 82984000
Price to Book Ratio 7.81
Return on Assets (%) 8.61
Return on Capital (%) 14.02
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.91
Total Assets 87.44
Total Liabilities 87.44
Total Equity 43.84
Share Outstanding 82984000
Price to Book Ratio 14.15
Return on Assets (%) 8.28
Return on Capital (%) 13.94
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 2.34
Total Assets 77.40
Total Liabilities 77.40
Total Equity 36.57
Share Outstanding 16596800
Price to Book Ratio 3.81
Return on Assets (%) 6.21
Return on Capital (%) 10.2
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.83
Total Assets 75.62
Total Liabilities 75.62
Total Equity 32.46
Share Outstanding 4149200
Price to Book Ratio 1.28
Return on Assets (%) 3.42
Return on Capital (%) 5.45
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.40
Total Assets 75.26
Total Liabilities 75.26
Total Equity 29.86
Share Outstanding 4149200
Price to Book Ratio 1.02
Return on Assets (%) 2.16
Return on Capital (%) 3.91
Particulars MAR 2024 (Values in Cr)
Net Income 11.57
Cash from Operations 5.84
Cash from Investing -2.67
Cash from Financing -0.49
Net change in Cash -0.48
Free Cash Flow 5.84
Particulars MAR 2023 (Values in Cr)
Net Income 10.09
Cash from Operations 10.66
Cash from Investing -6.60
Cash from Financing -1.81
Net change in Cash -0.25
Free Cash Flow 10.66
Particulars MAR 2022 (Values in Cr)
Net Income 6.48
Cash from Operations 7.65
Cash from Investing -1.75
Cash from Financing -5.77
Net change in Cash -1.66
Free Cash Flow 7.65
Particulars MAR 2021 (Values in Cr)
Net Income 2.59
Cash from Operations -10.38
Cash from Investing -16.96
Cash from Financing 18.28
Net change in Cash -9.99
Free Cash Flow 6.58
Particulars MAR 2020 (Values in Cr)
Net Income 2.21
Cash from Operations 1.54
Cash from Investing -3.08
Cash from Financing 2.59
Net change in Cash 0.48
Free Cash Flow 3.48
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.16 37.45 3.55 499.34 37.54 / 77.70
BLISS GVS PHARMA LTD 151.80 19.00 1.58 1598.94 92.25 / 172.40
CIPLA LTD 1454.20 25.44 4.14 117443.01 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 410.00 142.36 4.15 1206.67 145.00 / 440.00
GLAXOSMITHKLINE PHARMA LT 2345.45 49.56 23.75 39733.34 1664.75 / 3087.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.16 56.66 11.07 499.34 37.54 / 77.70
AMRUTAJAN HEALTH LTD 749.55 45.59 7.27 2167.00 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6595.05 128.08 24.26 16487.63 4050.15 / 8139.85
BLISS GVS PHARMA LTD 151.80 19.79 1.56 1598.94 92.25 / 172.40

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 49.20
  • 26 Days 51.10
  • 10 Days 48.60
  • 50 Days 50.70
  • 12 Days 48.40
  • 100 Days 47.40
  • 20 Days 50.40
  • 200 Days 79.80
49.26
PIVOT
First Resistance 50.53
Second Resistance 51.27
Third Resistance 52.54
First Support 48.52
Second Support 47.25
Third Support 46.51
RSI 49.65
MACD -2.72
Commodity Channel Index (CCI) 4.33
ADX 22.98
Williams % R -20.60

Over 1 Month

down

-18.29

Over 3 Months

down

10.72

Over 6 Months

down

22.85

Over 1 Year

down

-41.67

Over 3 Years

down

27.17

Over 5 Years

down

0.00

MEDICO REMEDIES LIMITED Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

MEDICO REMEDIES LIMITED Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
25.47
Promoter Holdings
73.33
FII
0.22
DII
0.96
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Haresh Kapurlal Mehta Shareholding of Promoter and Promoter Group 1.72292E7 20.76
Rishit Hareshbhai Mehta Shareholding of Promoter and Promoter Group 1.23E7 14.82
Harshit Haresh Mehta Shareholding of Promoter and Promoter Group 9520000.0 11.47
Rita H Mehta Shareholding of Promoter and Promoter Group 8628000.0 10.4
Shweta Harshit Mehta Shareholding of Promoter and Promoter Group 7260000.0 8.75
Priyal Rishit Mehta Shareholding of Promoter and Promoter Group 5200000.0 6.27
Ravi Goyal Huf Public Shareholding 3278300.0 3.95
Vijaygopal Parasram Atal Public Shareholding 1728000.0 2.08
Sanjay Narendra Bansal Public Shareholding 1248000.0 1.5
Harshit H Mehta Huf Shareholding of Promoter and Promoter Group 720000.0 0.87
Haresh K Mehta Huf Shareholding of Promoter and Promoter Group 0.0 0.0

MEDICO REMEDIES LIMITED

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
2021-11-17 2021-11-16 3:1
Ex-Date Old FV NEW FV Record Date
2023-03-16 10.0 2.0 2023-03-16

Learn More About Stocks

About MEDICO REMEDIES LIMITED

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by MEDICO REMEDIES LIMITED

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Medico Remedies Ltd?

Answer Field

The share price of Medico Remedies Ltd for NSE is ₹ 48.94 and for BSE is ₹ 49.11.

What is the Market Cap of Medico Remedies Ltd?

Answer Field

The market cap of Medico Remedies Ltd for NSE is ₹ 4,06.10 Cr. and for BSE is ₹ 0.0 Cr. as of now.

What is the 52 Week High and Low of Medico Remedies Ltd?

Answer Field

The 52 Week High and Low of Medico Remedies Ltd for NSE is ₹ 92.95 and ₹ 34.80 and for BSE is ₹ 92.87 and ₹ 35.00.

How to Buy Medico Remedies Ltd share?

Answer Field

You can trade in Medico Remedies Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Medico Remedies Ltd?

Answer Field

The 1 year returns on the stock has been -41.67%.

What is the Current Share Price of Medico Remedies Ltd?

Answer Field

Medico Remedies Ltd share price is for NSE ₹ 48.94 & for BSE ₹ 49.11 as on Dec 12 2024 03:30 PM.

What is the Market Cap of Medico Remedies Ltd Share?

Answer Field

The market cap of Medico Remedies Ltd for NSE ₹ 4,06.10 & for BSE ₹ 0.0 as on Dec 12 2024 03:30 PM.

What is the P/E Ratio of Medico Remedies Ltd Share?

Answer Field

As on Dec 12 2024 03:30 PM the price-to-earnings (PE) ratio for Medico Remedies Ltd share is 53.44.

What is the PB ratio of Medico Remedies Ltd Share?

Answer Field

As on Dec 12 2024 03:30 PM, the price-to-book (PB) ratio for Medico Remedies Ltd share is 6.68.

How to Buy Medico Remedies Ltd Share?

Answer Field

You can trade in Medico Remedies Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Medico Remedies Ltd Share on Bajaj Broking App?

Answer Field

To buy Medico Remedies Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Medico Remedies Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader